Drs. Melissa Pilewski and Monika Burness are co-directors of the Weiser Family Center for Breast Cancer Maize Block M Rogel Cancer Center University of Michigan Health

Breast Cancer

The Weiser Family Center for Breast Cancer gives patients access to surgeons, oncologists, radiation therapists, advanced practitioners, nurses, geneticists and counselors, pathologists and support staff with their sole focus on breast cancer.

The U-M Health Rogel Cancer Center's Weiser Family Center for Breast Cancer enhances lives through early detection, personalized treatment, and survivorship support, while advancing research, education, and advocacy. Led by Drs. Melissa Pilewskie and Monika Burness (shown in the photo above), the team has an unwavering commitment to make a meaningful difference, improving breast cancer outcomes for all.

Our expert team of internationally renowned clinicians offers comprehensive, personalized treatment, from early detection and treatment to survivorship support.

Key Features of Our Care:

  • Multidisciplinary Expertise: Patients consult with a team of surgical, medical, and radiation oncologists, plastic surgeons, social workers, and nurses, ensuring a holistic approach to care.
  • Collaborative Tumor Board: Our weekly tumor board brings together specialists to review cases and recommend personalized treatment plans, including access to clinical trials.
  • Advanced Treatment Options: We prioritize evidence-based treatments that are minimally invasive but maximally effective. Our team integrates the latest research in surgery, medical therapy and radiation to provide treatments that reduce risks and improve outcomes.
  • Patient Support: Emotional support and counseling are integral to our care, helping patients navigate their cancer journey with confidence.
  • Convenient Access: Appointments can be managed online through the MyUofMHealth patient portal or by calling 734-647-8902. Our services are available at multiple locations, including the Rogel Cancer Center, East Ann Arbor Health Center, and Brighton Center for Specialty Care.
  • Innovative Research: We offer access to cutting-edge treatments and clinical trials that are not available elsewhere, with a focus on minimizing side effects and improving long-term well-being.
  • Excellence in Reconstruction: Our plastic surgeons are leaders in breast reconstruction, offering both tissue-based and implant-based options, including advanced techniques like immediate lymphatic reconstruction lymphovenous anastomosis (LVA).
  • Specialized Support Services: We provide genetic counseling for hereditary cancer syndromes, access to fertility preservation services, sexual wellness counseling, lymphedema screening, and cold capping to reduce hair loss from chemotherapy.

Contact Us

Find a Doctor

Make an Appointment: 734-647-8902

Browse clinical trials

Cancer AnswerLine: 800-865-1125

Hear from our experts

Our Expertise Includes

Learn about breast cancer

Hereditary Breast Cancer

Hereditary cancer is a result from genetic mutations that are passed on from parents to offspring. A strong family history of cancer can indicate a hereditary risk. Genetic testing can be performed to check for a genetic predisposition to breast cancer and other cancer types.

Tumor Receptors

The two main hormones involved in breast cancer cell growth are estrogen and progesterone. When selecting appropriate breast cancer treatments, it is important to know the Estrogen Receptor (ER) and Progesterone Receptor (PR) status to determine prognosis and medical therapy options.

Metastatic Breast Cancer

Metastatic breast cancer is an advanced breast cancer, also known as stage IV breast cancer. It refers to cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body.

Breast Cancer & Young Women

Breast cancer in young women poses unique challenges and requires a comprehensive, multidisciplinary approach to treatment and care.

Breast Cancer & Older Adults

Breast cancer in older adults requires a multidisciplinary, personalized treatment approach that considers the patient’s overall health, comorbidities, functional status, and personal preferences.

Pregnancy & Breast Cancer

Pregnancy-associated breast cancer demands a thorough and nuanced approach to treatment and care, considering both maternal and fetal health.

Dr. Pilewski with a lymphedema patient

Lymphedema Screening and Early Detection Program

Lymphedema is a chronic condition resulting from the accumulation of lymphatic fluid, causing swelling or heaviness of the arm occurring after breast cancer treatment such as surgery or radiation therapy. Effective screening and early detection are crucial for managing and mitigating the severity of lymphedema.

Read about this program

Breast Cancer News and Stories

See all breast cancer news
ribbons in colorful colors lined up next to eachother
Health Lab

5-year survival rate has increased for all cancers, according to American Cancer Society

The American Cancer Society reports that mortality rates have continued to decline since the 1990s. N. Lynn Henry, of Michigan Medicine, answers questions about how factors such as healthy lifestyle choices, early screening and clinical trials have improved cancer survival rates.
woman wearing all pink and holding pink flower
Health Lab

Breast cancer patient encourages women to commit to their health

A Michigan Medicine patient learned as a young woman that she had a BRCA1 mutation. Her dedication to yearly mammograms helped her catch her cancer early.
puzzle looking string of orange with lab gloves blue
Health Lab

Capturing cancer cells from blood could help doctors choose the right breast cancer treatment

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood, study from the University of Michigan and the University of Kansas suggests.
close up microscopic image in pinks
Health Lab

What is ductal carcinoma in situ breast cancer?  

A Michigan Medicine breast cancer expert discusses diagnosis, treatment and risk factors of Ductal Carcinoma In Situ (DCIS) and what you should know.
pill being taken close up with water near hand
Health Lab

Patients are opting in for 10 years of breast cancer treatment

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a recent study sheds light on whether patients are opting for it.
white pills falling out of orange pill bottle on a brown surface
Health Lab

Drug combination reduces breast cancer risk and improves metabolic health in rats

Researchers investigated the combined effects of bazedoxifene and conjugated estrogens in rat models as an alternative to tamoxifen.